|
| 36928484 | Patient-Specific Considerations, the GABA Pathway, and New Clinical Trial Data on Neuroactive Steroids in MDD and PPD. | | 2023 |
| 37132201 | Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial. | Am J Psychiatry | 2023 |
| 36811520 | Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. | J Clin Psychiatry | 2023 |
| 35102537 | Pharmacotherapy for Sexual Dysfunction in Women. | Current Psychiatry Reports | 2022 |
| 36356250 | Accidental Flibanserin Ingestion in Children Causing Acute Respiratory and Central Nervous System Depression: What Health Care Professionals Need to Know. | Obstetrics and Gynecology | 2022 |
| 36400683 | Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder. | Sexual Medicine | 2022 |
| 36591547 | Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis. | | 2022 |
| 36529480 | Response to Commentary by Spielmans. | | 2022 |
| 33860405 | An Innovative Model of Behavior Management to Address Behavioral Emergencies in the Acute Medical Inpatient Setting: Pilot Data. | Journal of Clinical Psychology in Medical Settings | 2022 |
| 33455598 | The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. | CNS Spectrums | 2022 |
| 35255754 | Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management. | Expert Opinion on Drug Safety | 2022 |
| 35230162 | Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. | Journal of Women's Health | 2022 |
| 35147466 | Safety Profile of Bremelanotide Across the Clinical Development Program. | Journal of Women's Health | 2022 |
| 34772322 | Response to Balon's Commentary: Is Basson's Model of Sexual Response Relevant? | Journal of Sex and Marital Therapy | 2022 |
| 34999484 | Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin. | Sexual Medicine | 2022 |
| 35178587 | Including partners in discussions of sexual side effects from breast cancer: a qualitative study of survivors, partners, and providers. | Support Care Cancer | 2022 |
| 34483765 | Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options. | | 2021 |
| 34080054 | Addressing sexual concerns of female breast cancer survivors and partners: a qualitative study of survivors, partners, and oncology providers about Internet intervention preferences. | Support Care Cancer | 2021 |
| 33835907 | Failure of a Meta-analysis: A Commentary on Glen Spielmans's "Re-Analyzing Phase III Bremelanotide Trials for 'Hypoactive Sexual Desire Disorder in Women'". | Journal of Sex Research | 2021 |
| 34150359 | Blood-Brain Barrier: COVID-19, Pandemics, and Cytokine Norms. | Innovations in Clinical Neuroscience | 2021 |
| 32800563 | The Evolution of the Female Sexual Disorder/Dysfunction Definitions, Nomenclature, and Classifications: A Review of DSM, ICSM, ISSWSH, and ICD. | Sexual Medicine Reviews | 2021 |
| 31010445 | Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. | CNS Spectrums | 2020 |
| 31855607 | Evaluation of safety for flibanserin. | Expert Opinion on Drug Safety | 2020 |
| 31735618 | Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study. | Journal of Sexual Medicine | 2020 |
| 32096691 | Instruments for Screening, Diagnosis, and Management of Patients with Generalized Acquired Hypoactive Sexual Desire Disorder. | Journal of Women's Health | 2020 |
| 33136923 | Effect of Brexpiprazole on Prolactin and Sexual Functioning: An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder. | Journal of Clinical Psychopharmacology | 2020 |
| 31204297 | Lumping, Splitting, and Treating: Therapies Are Needed for Women With Overlapping Sexual Dysfunctions. | Sexual Medicine Reviews | 2019 |
| 31599847 | Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. | Obstetrics and Gynecology | 2019 |
| 31599840 | Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. | Obstetrics and Gynecology | 2019 |
| 32082942 | Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II. | Innovations in Clinical Neuroscience | 2019 |
| 29095125 | Corrigendum. | Journal of Sex and Marital Therapy | 2019 |
| 31522985 | Effects of Timing of Flibanserin Administration Relative to Alcohol Intake in Healthy Premenopausal Women: A Randomized, Double-Blind, Crossover Study. | Journal of Sexual Medicine | 2019 |
| 31519497 | Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects. | Sexual Medicine | 2019 |
| 31277966 | Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. | Journal of Sexual Medicine | 2019 |
| 31078200 | Female Sexual Dysfunction. | Medical Clinics of North America | 2019 |
| 30803922 | Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications. | Sex Med Rev | 2019 |
| 31405765 | Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial. | Journal of Sexual Medicine | 2019 |
| 30846116 | Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III. | Journal of Sexual Medicine | 2019 |
| 29576442 | Effect Size in Efficacy Trials of Women With Decreased Sexual Desire. | Sexual Medicine Reviews | 2018 |
| 30224026 | A Brief Version of the Sexual Interest and Desire Inventory-Female With 4 Core Items. | Journal of Sexual Medicine | 2018 |
| 30251897 | Expert opinion on existing and developing drugs to treat female sexual dysfunction. | Expert Opinion on Emerging Drugs | 2018 |
| 30086213 | Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial. | Journal of Clinical Psychiatry | 2018 |
| 29987939 | Sexual well-being after menopause: An International Menopause Society White Paper. | Climacteric | 2018 |
| 29523488 | Evaluation and Management of Hypoactive Sexual Desire Disorder. | Sexual Medicine | 2018 |
| 29289374 | Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study. | Journal of Sexual Medicine | 2018 |
| 29371145 | Assessment of Sexual Desire for Clinical Trials of Women With Hypoactive Sexual Desire Disorder: Measures, Desire-Related Behavior, and Assessment of Clinical Significance. | Sexual Medicine Reviews | 2018 |
| 29545008 | The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. | Mayo Clin Proc | 2018 |
| 29541946 | Sex Differences in the Treatment of Sexual Dysfunction. | Current Psychiatry Reports | 2018 |
| 28024687 | Thoughts on the U.S. Food and Drug Administration (FDA) Draft Guidance on Low Sexual Desire and Arousal. | Sexual Medicine Reviews | 2017 |
| 28757356 | Flibanserin: From Bench to Bedside. | Sexual Medicine Reviews | 2017 |